India's Pharmaceutical Exports

Country Profile

Mexico

Mexico is a major destination for Indian pharmaceutical exports — $450M in FY 2025–26, with 4.6× growth over the past decade. Medicines accounts for 53% of shipments, with vaccines contributing $87.7M. The compound annual growth rate since FY2015 stands at 14.8%.

🇲🇽 #21 Destination · $450M · 4.6× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$450M
Exports FY2025–26 DGCIS
4.6×
Growth FY2015→2026
1.5%
Share of India Total
#21
Rank Among 178 Markets
14.8%
CAGR FY2015→2026
Mexico is a major destination for Indian pharmaceutical exports — $450M in FY 2025–26, with 4.6× growth over the past decade. Medicines accounts for 53% of shipments, with vaccines contributing $87.7M. The compound annual growth rate since FY2015 stands at 14.8%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $238M (53.0%) Medicine Ingredients $97.9M (21.8%) Vaccines $87.7M (19.5%) Surgical & Hospital Supplies $17.8M (4.0%) Traditional & Herbal $8.00M (1.8%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Mexico in the RBI overseas direct investment dataset (2011–2026).